Stock Symbol:

AVNR

Company Name:

AVANIR Pharmaceuticals, Inc.

Company Description:

AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States and Canada.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

F-M-A-N

Stock Exchange:

NASDAQ

Predicted Split Price:

$41.00

Predicted Split Ratio:

3 for 2

5 Day Performance After Split:

3.2%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.